Seroprevalence

Since identification of SARS-CoV-2 and the ensuing pandemic, epidemiologic studies have shown that COVID-19 outcomes are less severe among children than adults (1–8). Conclusions drawn from published studies on COVID-19 prevalence in the pediatric population have varied (5,9–16), possibly because of differences in mitigation measures, community transmission rates, and case ascertainment practices . . .

Since identification of SARS-CoV-2 and the ensuing pandemic, epidemiologic studies have shown that COVID-19 outcomes are less severe among children than adults (1–8). Conclusions drawn from published studies on COVID-19 prevalence in the pediatric population have varied (5,9–16), possibly because of differences in mitigation measures, community transmission rates, and case ascertainment practices . . .